192 related articles for article (PubMed ID: 21914583)
1. Residents' corner September 2011. Residents' editorial choice.
Feldmeyer L; Guenova E; Torres T; Nosbaum A
Eur J Dermatol; 2011; 21(5):826-7. PubMed ID: 21914583
[No Abstract] [Full Text] [Related]
2. [Biological dermatologic agents. The Danish Society of Dermatology].
Iversen L; Kragballe K;
Ugeskr Laeger; 2007 Mar; 169(12):1100. PubMed ID: 17394811
[No Abstract] [Full Text] [Related]
3. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
4. Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha.
Konjević G; Jović V; Radulović S; Jelić S; Dzodić R; Spuzić I
Neoplasma; 2001; 48(3):175-81. PubMed ID: 11583285
[TBL] [Abstract][Full Text] [Related]
5. [Dacarbazine: deticene].
Quéreux G; Brocard A; Dréno B
Ann Dermatol Venereol; 2007 Dec; 134(12):1001-3. PubMed ID: 18166926
[No Abstract] [Full Text] [Related]
6. Temozolomide for advanced, metastatic melanoma.
Cohen MH; Johnson JR; Middleton MR
J Clin Oncol; 2000 May; 18(10):2185. PubMed ID: 10811684
[No Abstract] [Full Text] [Related]
7. [Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate].
Strannegärd O; Thorén FB; Lundgren E
Lakartidningen; 2008 Feb 6-12; 105(6):358-61. PubMed ID: 18380352
[No Abstract] [Full Text] [Related]
8. Has targeted therapy for melanoma made chemotherapy obsolete?
Gibney GT; Sondak VK
Lancet Oncol; 2013 Jul; 14(8):676-7. PubMed ID: 23816289
[No Abstract] [Full Text] [Related]
9. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
10. A host of novel agents for treating psoriasis, psoriatic arthritis stir interest.
Lamberg L
JAMA; 2003 Jun; 289(21):2779-80, 2783. PubMed ID: 12783895
[No Abstract] [Full Text] [Related]
11. [Disseminated melanoma treatment].
Neidhardt-Bérard EM; Négrier S
Rev Prat; 2004 Jun; 54(11):1210-4. PubMed ID: 15496028
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.
Rasi G; Terzoli E; Izzo F; Pierimarchi P; Ranuzzi M; Sinibaldi-Vallebona P; Tuthill C; Garaci E
Melanoma Res; 2000 Apr; 10(2):189-92. PubMed ID: 10803720
[No Abstract] [Full Text] [Related]
13. Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine.
Busch C; Geisler J; Knappskog S; Lillehaug JR; Lønning PE
J Invest Dermatol; 2010 Oct; 130(10):2514-6. PubMed ID: 20505745
[No Abstract] [Full Text] [Related]
14. NRAS-mutant melanoma: response to chemotherapy.
Soon CW; Algazi AP; Cha EN; Webb EM; Daud AI
Arch Dermatol; 2011 May; 147(5):626-7. PubMed ID: 21576590
[No Abstract] [Full Text] [Related]
15. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
16. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma.
Treudler R; Georgieva J; Geilen CC; Orfanos CE
J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966
[TBL] [Abstract][Full Text] [Related]
17. Treatment of inflammatory dermatoses with novel biologic agents: a primer.
Nussbaum R; Krueger JG
Adv Dermatol; 2002; 18():45-89. PubMed ID: 12528402
[No Abstract] [Full Text] [Related]
18. Node positive melanoma--a positive note?
Kelly J; Kerin MJ
Surgeon; 2012 Apr; 10(2):63-4. PubMed ID: 22385525
[No Abstract] [Full Text] [Related]
19. Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
Najar HM; Dutz JP
J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132
[TBL] [Abstract][Full Text] [Related]
20. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
Punt CJ; Suciu S; Gore MA; Koller J; Kruit WH; Thomas J; Patel P; Lienard D; Eggermont AM; Keilholz U
Eur J Cancer; 2006 Nov; 42(17):2991-5. PubMed ID: 17023156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
